Home › Funds › Melqart Asset Management (UK) Ltd › CPRX
Melqart Asset Management (UK) Ltd position in CPRX
CATALYST PHARMACEUTICALS INC
Melqart Asset Management (UK) Ltd reported holding 247,556 shares of CPRX (CATALYST PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$7.8M, representing 0.74% of its reported portfolio and ranking #34 among its reported holdings. Melqart Asset Management (UK) Ltd first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Melqart Asset Management (UK) Ltd's CPRX position evolved
Melqart Asset Management (UK) Ltd first disclosed a stake in CPRX in Q2 2026 at 247,556 shares (US$7.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 247.56K | $7.78M | New |
About CPRX and 13F data
CPRX (CATALYST PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 43 other funds we track also report a position in CPRX — the largest reported positions include GLAZER CAPITAL, LLC (US$113.2M), HBK INVESTMENTS L P (US$88.6M), NEXPOINT ASSET MANAGEMENT, L.P. (US$50.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CPRX
- GLAZER CAPITAL, LLC 3.60M sh · $113.24M · Q2 2026
- HBK INVESTMENTS L P 2.82M sh · $88.64M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 1.60M sh · $50.37M · Q2 2026
- Polar Asset Management Partners Inc. 1.15M sh · $36.15M · Q2 2026
- WATER ISLAND CAPITAL LLC 933.82K sh · $29.35M · Q2 2026
- KENNEDY CAPITAL MANAGEMENT LLC 856.61K sh · $26.92M · Q2 2026
- Sagefield Capital LP 569.48K sh · $17.90M · Q2 2026
More on Melqart Asset Management (UK) Ltd
FAQ
How long has Melqart Asset Management (UK) Ltd held CPRX?
Melqart Asset Management (UK) Ltd has disclosed CPRX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Melqart Asset Management (UK) Ltd's current position in CPRX?
As of Q2 2026, Melqart Asset Management (UK) Ltd holds 247.56K shares of CPRX (CATALYST PHARMACEUTICALS INC), valued at $7.78M, representing 0.74% of its reported portfolio and ranking #34.
Has Melqart Asset Management (UK) Ltd been buying or selling CPRX?
In the latest 13F filing (Q2 2026), Melqart Asset Management (UK) Ltd newly opened its position in CPRX.
Which other funds hold CPRX?
Other major institutional holders of CPRX include GLAZER CAPITAL, LLC, HBK INVESTMENTS L P, NEXPOINT ASSET MANAGEMENT, L.P., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.